Bayanin Kamfanin
Beijing Succeeder Technology Inc. (wanda ake kira SUCCEEDER), yana a filin shakatawa na Life Science Park a birnin Beijing, wanda aka kafa a shekarar 2003, SUCCEEDER ya ƙware a kan thrombosis da samfuran gwajin jini don kasuwar duniya.
A matsayin daya daga cikin manyan kamfanoni a cikin kasuwar gano cutar sankara ta kasar Sin na Thrombosis da Hemostasis, SUCCEEDER ya sami ƙwararrun ƙungiyoyin R&D, Production, Tallace-tallace, Talla da Sabis, Samar da masu nazarin coagulation da reagents, masu nazarin rheology na jini, masu nazarin ESR da HCT, masu nazari na tara platelet, tare da ISO 13485, CE Takaddun shaida, da FDA da aka jera.
R&D
A matsayin daya daga cikin manyan kamfanoni a cikin kasuwar gano cutar sankara ta kasar Sin na Thrombosis da Hemostasis, SUCCEEDER ya sami ƙwararrun ƙungiyoyin R&D, Production, Tallace-tallace, Talla da Sabis, Samar da masu nazarin coagulation da reagents, masu nazarin rheology na jini, masu nazarin ESR da HCT, masu nazari na tara platelet, tare da ISO 13485, CE Takaddun shaida, da FDA da aka jera.
Tun lokacin da aka kafa shi a cikin 2003, Succeeder ya himmatu ga bincike da haɓakawa, samarwa da siyar da kayan gwaji, reagents da abubuwan amfani a fagen thrombosis da hemostasis in vitro diagnostics, samar da cibiyoyin kiwon lafiya tare da na'urorin gwaji ta atomatik don coagulation jini, rheology na jini. , hematocrit, platelet aggregation, goyon bayan reagents da abubuwan amfani.Succeeder ow babban kamfani ne na kasar Sin a fannin binciken in vitro na thrombosis da hemostasis.
An ƙirƙiri ainihin fasahar Succeeder da ke rufe kayan kida, reagents da abubuwan da ake amfani da su, tare da ƙwararrun R&D masu zaman kansu da ƙwarewar ƙirƙira na fasaha.A halin yanzu, tana da manyan nau'ikan fasaha guda biyar: dandamalin fasahar auna jini na jini, dandamalin fasahar gwajin cutar coagulation na jini, dandamalin fasahar albarkatun albarkatun halittu, ainihin fasahar gano magungunan coagulation, da hanyoyin ganowa.
Muhimmi
Daraja
Inganta fasahar aunawa da matakin sarrafa kansa na masu gwajin coagulation na yanzu da masu gwajin jini;
(2) R&D Layin coagulation na jini, mai gwajin jini mai sauri ta atomatik, mai gwajin jini na jini mai sauri, mai tantance aikin platelet ta atomatik da ginshiƙi na thromboelasticity da sauran jerin samfuran;
(3) Gane m samar da sama key albarkatun kasa, dogara da nazarin halittu albarkatun kasa fasahar dandali, inganta inganci da yi na reagent kayayyakin;
(4) Haɓaka vWF, LA, PC, PS, Anti-Xa, diluted thrombin lokacin ma'auni (dTT), jini coagulation factor VIII da jini coagulation factor IX da sauran in vitro diagnostic reagents da goyon bayan ingancin iko Products da daidaitattun kayayyakin hadu da asibiti. Bukatun bincike da saka idanu na thrombus, cututtukan antiphospholipid, hemophilia da sauran cututtuka, da kiyaye fa'idodin ƙwararrun ƙwararrun Succeeder a fagen ganewar in vitro na thrombosis da hemostasis.
Takaddun shaida
Katin kasuwanci
WeChat na Sinanci
Turanci WeChat